Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 1c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.52), $0.01 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $844 thousand versus the consensus estimate of $870 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Albemarle names Max Hood as chief accounting officer
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings